GlassScriptPhysician profile
Jamie Stodd
NPI 1780011981
$1,105.31
in general payments reported to CMS, 2019-2025
13 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $226 · 2024: $482 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $204.19 | 2023-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $116.43 | 2024-2025 | |
| Genzyme Corporation | $113.53 | 2023-2025 | |
| Amgen INC. | $106.27 | 2024-2025 | Otezla, Otezla |
| Verrica Pharmaceuticals INC. | $104.17 | 2023 | Ycanth |
| Ucb, INC. | $86.08 | 2023-2024 | Cimzia, Bimzelx |
| Regeneron Healthcare Solutions, INC. | $79.64 | 2024-2025 | Dupixent |
| Lilly USA, LLC | $73.12 | 2024-2025 | Taltz, Olumiant, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $72.19 | 2023-2024 | Sotyktu |
| Abbvie INC. | $68.12 | 2023-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.67 | 2025 | Cabtreo |
| Almirall LLC | $28.52 | 2024 | Klisyri |
| Biofrontera INC. | $23.38 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Stodd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.